Skip to content

Public FDA record

Z-0444-2021: SUNG HWAN E&B VIVACE Shenb Innovation of Beauty Technologyt - Product Usage: intended for use in the der

Recall record Z-0444-2021 for Aesthetics Biomedical, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0444-2021
Company in FDA record
Aesthetics Biomedical, Inc.
FDA record creation date
Nov 12, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

A high frequency output (2 MHz) has not been cleared for distribution in the U.S.

Source facts

Action
On 03/13/2020, the firm sent a customer notification letter via USPS informing customer that it was discovered that their RF Microneedling device contains the 2 MHz power level that has not been cleared for use within the United States. The Recalling Firm is offering the following offers: 1) Customers may have the 2MHz capability disabled until regulatory clearance is received. The Recalling Firm will arrange, at their expense, a convenient time with the customer's office to take this action. The planned field correction includes a replacement CPU to disable 2MHz functionality, but also provides the ability to reactivate the 2MHz with a password upon receipt of FDA clearance, which is currently underway. 2) Customers may voluntarily choose not to have a field correction completed and retain the current functionality of the Vivace device. The Recalling Firm is also asking that customers go to https://www.aestheticsbiomedical.com/request-for-service/ to respond with your decision either to: 1) Disable the 2MHz feature on your device, OR 2) Not to participate in the voluntary recall. The Recalling Firm will follow-up on all affirmative responses, to make arrangements with your practice, to execute the field correction. Our response time for field corrections will be contingent upon the status of COVID 19 and related travel authorities. Until we can arrange a correction we suggest you simply not use the 2MHz setting. If customers have further questions regarding the field correction, information on treatment protocols for use of the 1MHz setting, or have other questions on this topic please email the Recalling Firms standing device hotline at devicehotline@aestheticsbiomed.com. The Recalling Firm will return the email within 48 business hours. In addition, the Recalling Firm has posted the customer notification on its website: https://www.aestheticsbiomedical.com/press-releases/fda-cleared-vivace-remains-available/
Initiated
2020-03-13
Root cause
No Marketing Application
Terminated
2021-09-01
Distribution
U.S. Nationwide distribution including in the states of AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, and WY.
Recall number
Z-0444-2021
Recall status
Terminated
CDRH record ID
182047
FDA record created
2020-11-12
Recall event number
85891

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗